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Protease recognition sites in  
Bet v 1a are cryptic, explaining its 
slow processing relevant to  
its allergenicity
Regina Freier, Elfriede Dall & Hans Brandstetter
Despite a high similarity with homologous protein families, only few proteins trigger an allergic 
immune response with characteristic TH2 polarization. This puzzling observation is illustrated by the 
major birch pollen allergen Bet v 1a and its hypoallergenic protein isoforms, e.g., Bet v 1d. Given the 
key role of proteolytic processing in antigen presentation and T cell polarization, we investigated the 
recognition of Bet v 1 isoforms by the relevant protease cathepsin S. We found that at moderately 
acidic pH values Bet v 1a bound to cathepsin S with significantly lower affinity and was more slowly 
cleaved than its hypoallergenic isoform Bet v 1d. Only at pH values ≤4.5 the known proteolytic 
cleavage sites in Bet v 1a became accessible, resulting in a strong increase in affinity towards 
cathepsin S. Antigen processing and class II MHC loading occurs at moderately acidic compartments 
where processing of Bet v 1a and Bet v 1d differs distinctly. This difference translates into low and 
high density class II MHC loading and subsequently in TH2 and TH1 polarization, respectively.
Allergic reactions to proteins of the pathogenesis-related protein family number 10 (PR-10) are mainly 
related to birch pollen. Additionally more than 70% of patients have pollen-related food allergy1. The 
cross-reactive plant proteins have up to 75% sequence similarity, and all known structures of these 
cross-reactive proteins share a highly conserved fold2. Nevertheless only Bet v 1, the major allergen 
from birch pollen, is considered to have the capacity to trigger the initial allergic response3,4. The com-
parison between isolated and recombinant Bet v 1 led to the discovery of thirteen different isoforms 
(1.0101 to 1.3001, formerly a-n) with more than 95% sequence identity. Mass spectrometry revealed that 
Bet v 1a (1.0101) represents at least 50% of the total mass of pollen Bet v 15 while Bet v 1d (1.0401) is 
present with approximately 10%6. Despite the high sequential and structural identity, allergen isoforms 
can differ drastically in their allergenic potential. Only Bet v 1a induces high IgE antibody production, 
while Bet v 1d triggers IgG4 expression. Consequently Bet v 1a acts as the sensitizing allergen whereas 
the hypoallergenic Bet v 1d mainly induces a protective immune response7. This might be a general 
feature of allergens, as hypoallergenic variants were identified in several species8. The prerequisite for 
IgE production is the polarization of naïve T cells to TH2 cells, which subsequently release cytokines to 
stimulate IgE production in B cells. It was shown that antigen density on the surface of antigen presenting 
cells (APCs) is one of the important factors that influence the fate of a naïve CD4+ T cell. High con-
centrations of class II MHC loaded with antigen-derived peptides promote TH1-like responses, whereas 
a lower density supports TH2 cell differentiation9. Antigenic peptides are generated by endolysosomal 
proteases, mostly papain-like cysteine cathepsins S, L, B and V, but also by aspartate cathepsins D and 
E10. Cathepsin L is mostly found in the thymus where it plays important roles in the antigen processing 
and presentation with relevance to tolerance induction, but to a lesser extent in dendritic cells (DCs). In 
contrast, cathepsin S is predominantly expressed in professional APCs, namely DCs and B cells11. Using 
activity based probes it was shown that antigens are selectively targeted to cathepsin S in DCs, and are 
Department of Molecular Biology, University of Salzburg, Billrothstr. 11, A-5020 Salzburg, Austria. Correspondence 
and requests for materials should be addressed to H.B. (email: hans.brandstetter@sbg.ac.at)
received: 01 April 2015
Accepted: 08 July 2015
Published: 03 August 2015
OPEN
www.nature.com/scientificreports/
2Scientific RepoRts | 5:12707 | DOi: 10.1038/srep12707
only poorly recognized by other cathepsins12. Moreover, in a comparative study of cathepsin B, C, L and 
S cathepsin L was found to be most effective under lysosomal conditions, albeit also active under endoso-
mal conditions13. By contrast, cathepsin S activity was shown to be much stronger in the endosome than 
in the lysosome14. This suggests that cathepsin S is the major protease in early recognition and relevant 
for the cleavage of antigens. Indeed, the majority of Bet v 1 antigenic peptides, which were produced by 
extracts of endolysosomal proteases, could be generated by cathepsin S alone15.
We therefore used Bet v 1a and Bet v 1d as sensitizing and hypoallergenic model allergens to study 
differences in the recognition by cathepsin S. The major aim of this study was to find out why hypoal-
lergenic isoforms differ drastically in their immune response, although they have almost identical 
sequences. Structural dynamics and flexibility can be different between highly similar isoforms, which 
cannot be derived from crystal structures16. In this work we wanted to analyze if structural flexibility is 
a key difference between hypoallergenic and sensitizing allergens.
Results
Early Bet v 1 cleavage sites are not accessible to proteases. The early endosomal cleavage sites 
in Bet v 1a have been identified and replicated in an in vitro cathepsin S cleavage assay15. Surprisingly, 
detailed analysis of the Bet v 1a structure revealed that none of them is easily accessible to the active 
site of proteases, as they are mostly located in secondary structure elements (Fig. 1a). Additionally, crys-
tal structures of hypoallergenic and sensitizing Bet v 1 isoforms are remarkably similar (Fig.  1b). This 
counterintuitive observation prompted us to investigate whether and to which extent cathepsin S could 
recognize Bet v 1a and whether the comparison of the cathepsin S—Bet v 1d recognition could reveal a 
molecular link to their different allergenic properties.
Binding of Bet v 1 isoforms to immobilized cathepsin S revealed low affinity sites in Bet v 
1a, but high affinity sites in Bet v 1d. To study the binding of allergen isoforms to cathepsin S, the 
C25A inactivated protease was immobilized on a sam5 chip. Its structural integrity was confirmed by 
high affinity cystatin C binding, an endogenous inhibitor of cathepsin S (Fig. S1). The overall affinity of 
Figure 1. Bet v 1 cleavage sites are cryptic and require reordering for protease access. (a) Initial 
recognition sites are harboured within secondary structures. The initial recognition sites15 were mapped into 
the crystal structure of Bet v 1a (PDB: 4A88). Cleavage sites are indicated with black arrows. The sites are 
embedded within α -helices (sites I, IV), a 1–4 tight turn (site II), or a β -sheet (site III) (b) Crystal structures 
of sensitizing Bet v 1a (PDB 4A88, dark grey) and hypoallergenic Bet v 1l (PDB 1FM432, green) share a 
highly conserved fold. Cathepsin S recognition sites are located in stabilized regions. The structure-based 
alignment was performed with topmatch33 (c) Differences in sequence between Bet v 1a and Bet v 1d (red 
letters) do not coincide with cathepsin S cleavage sites. The secondary structure is indicated below each row. 
Coloured backgrounds represent the protease recognition sites from the non-primed site P3 to the primed 
site P3’. The scissile bond is marked by a black arrow. The alignment was created with ClustralW34 and 
modified with Aline35.
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the hypoallergenic isoform Bet v 1d to cathepsin S was approximately four times higher compared to the 
sensitizing allergen Bet v 1a (Fig. 2). This finding suggested to us that the substrate recognition sites are 
hardly accessible in Bet v 1a, consistent with our structural analysis (Fig. 1a). By contrast, the recognition 
sites must be dynamically more accessible in Bet v 1d.
To test this interpretation, we compared the degradation kinetics of Bet v 1a and Bet v 1d by active 
wild type cathepsin S. We found that the Bet v 1a degradation was significantly retarded as compared to 
more rapidly digested Bet v 1d (Fig. 3), reflecting their differences in binding to cathepsin S.
As illustrated in Fig. 1, Bet v 1 is processed by cathepsin S at several distinct sites. Therefore the here 
measured affinities should represent an average of the initial recognition sites. Consistent herewith, the 
binding sensograms typically feature a biphasic association curve with a relatively sharp initial increase 
in binding followed by a shallow secondary phase. This observation is suggesting that different Bet v 1 
recognition sites differ in their affinity towards cathepsin S.
Bet v 1a and Bet v 1d share a high sequence identity of ~95%, i.e. their amino acid sequences differ 
only at 7 positions. Notably, these point mutations do not overlap with the initial cathepsin S recognition 
sites, implying that they are at structurally different positions on Bet v 1 (Fig. 1c). Also the crystal struc-
tures of hypoallergenic and sensitizing isoforms are virtually identical (Fig. 1b). Therefore, the observed 
differences in binding affinities and cleavage kinetics of the two Bet v 1 isoforms cannot be explained by 
the comparison of their sequence or crystal structures.
Figure 2. Binding affinity of cathepsin S is four times higher towards Bet v 1d than Bet v 1a. In trans 
activated C25A-cathepsin S was immobilized on a sam® 5BLUE biosensor chip. Its binding to Bet v 1a and 
Bet v 1d was measured at pH 6.7 in a concentration range from 10 to 100 μ M. The 4–5 fold increased phase 
shift in Bet v 1d as compared to Bet v 1a reflects their differences in binding. KD app for Bet v 1a and Bet 
v 1d were calculated to be 21.5 ± 9.3 μ M and 5.4 ± 0.8 μ M respectively. The sensograms of 2 independent 
measurements are shown for Bet v 1a (top) and Bet v 1d (bottom) binding. The calculated dissociation 
constant KD app represents an average affinity of initial Bet v 1 recognition sites (I to IV). Correspondingly, 
the enlarged view shows biphasic binding for Bet v 1a at low concentrations.
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We therefore postulated that both Bet v 1 isoforms undergo conformational transitions preceding or 
upon complex formation with cathepsin S, rendering the cleavage sites accessible for proteolysis. The 
observed differences in cathepsin S binding and processing could then be explained by the higher or 
lower energetic barrier that needs to be overcome by Bet v 1a or Bet v 1d, respectively. Indeed, minimal 
changes in the amino acid sequence can have a significant impact on fold stability and flexibility17.
Differences in the fold flexibility of Bet v 1 isoforms relate to their different affinities towards 
cathepsin S. To test the relevance of the substrates’ fold stability and flexibility for cathepsin S bind-
ing, we compared the binding affinities of native and thermally destabilized Bet v 1 molecules. To obtain 
structurally destabilized Bet v 1, the protein was shortly incubated at 60 °C, close to its melting point 
of Tm = 64 °C18. Only soluble, monodisperse fractions of thermally destabilized Bet v 1 were used for 
cathepsin S binding experiments. We found that the affinities of the Bet v 1 isoforms to cathepsin S con-
verged under destabilizing conditions (Fig. 4). This convergence is due to a five-fold reduction in affinity 
of Bet v 1d. This change in affinities indicates that the substrate’s fold is indeed important for recognition 
by the enzyme cathepsin S. The fold encodes an isoform-specific protein dynamics that is critical for the 
higher affinity of Bet v 1d than that of Bet v 1a.
Figure 3. Degradation of Bet v 1a by active wild type cathepsin S was significantly slower as compared 
to more rapidly digested Bet v 1d. A ratio of 1:10 protease to substrate was incubated at 37 °C at pH 
5. Samples were taken after 0, 0.5, 1, 3, 5 and 24 h. In a control experiment Bet v 1 was incubated for 24 h 
at 37 °C at pH 5 without addition of cathepsin S. Bet v 1d degradation after 1h corresponded to Bet v 1a 
degradation after 24 h.
Figure 4. Convergence of binding affinities upon structural destabilization. Whereas Bet v 1a maintained its 
binding affinity towards cathepsin S, the affinity of Bet v 1d significantly decreased upon thermal destabilization, 
resulting in an effective convergence of the binding affinities of both isoforms. Binding affinities to immobilized 
cathepsin S were measured at pH 6.7. Affinities of heat-treated Bet v 1a and Bet v 1d were measured after spin 
filtration with the same concentrations. Bars represent the mean affinity of 5 measurements; errors show 
standard deviations.
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Acidic pH is necessary for Bet v 1a, but not Bet v 1d recognition. Since the fold stability of a 
protein is dependent on several factors such as pH we next analyzed the effect of different pH values 
on cathepsin S–Bet v 1 complex formation. This factor was especially interesting, since pH is important 
in the maturation of the endosome. Interestingly, we found that Bet v 1a binding to cathepsin S is pH 
dependent: pH ≤ 4.5 resulted in a significant increase in binding as compared to neutral pH. Importantly, 
the recognition of Bet v 1a by cathepsin S at neutral and slightly acidic pH was very low (Fig.  5a). 
As shown previously, the Bet v 1a affinity towards cathepsin S depended on its fold and the encoded 
dynamics. Therefore, we conclude that the fold encoded dynamics of Bet v 1a is similarly pH dependent. 
In contrast, Bet v 1d was bound already at neutral pH, with steadily, but less pronounced increase in 
binding with lowering pH (Fig. 5b). Furthermore, the binding curves of Bet v 1a and Bet v 1d converge 
at acidic pH values, indicating a comparable dynamics of both isoforms.
Discussion
Hyperallergenic and hypoallergenic isoforms of the birch pollen allergen Bet v 1 spotlight a key problem 
in allergology, namely the causal linkage of molecular properties with their sensitizing potential. In the 
current study we found low affinity binding of Bet v 1a, but high affinity binding of Bet v 1d, to cathep-
sin S; the latter protease is critical in its antigen processing15. In line with these findings, cathepsin S 
processed Bet v 1a significantly more slowly than Bet v 1d. Given their high sequential and structural 
similarity, these findings are intriguing and could be explained by differences in the dynamics of the Bet 
v 1 isoforms. Importantly, acidic pH ≤ 4.5 triggered the conformational changes that resulted in signifi-
cantly faster binding to cathepsin S, which was then comparable to Bet v 1d. The underlying molecular 
mechanism most likely is a better accessibility of the Bet v 1a recognition sites due to increased structural 
flexibility at low pH.
The pH value is a key factor in endosomal processing and endocytosed proteins experience an 
increased acidification from pH 7 to pH 4 during endosomal maturation. APCs have developed strate-
gies to prevent the rapid acidification of endosomal compartments. This allows proteins to remain intact 
for a longer period of time, which is a prerequisite for the presentation pathway of antigens19,20 (Fig. 6). 
Consequently a continuous supply of intact protein allows persistent generation of peptides suitable for 
presentation (> 12 aa). Our results show that the non-sensitizing Bet v 1d will be preferentially processed 
in the late endosome (LE) at slightly acidic pH (≥ 5.521), resulting in antigenic peptides for class II MHC 
presentation; by contrast, only few antigenic peptides will result from Bet v 1a at this milieu. Cathepsin 
S is, unlike many other lysosomal cysteine proteases, stable and active under a broad pH range, includ-
ing the class II MHC presentation compartment22. Indeed relatively high levels of cathepsin S activity 
were detected in the early endosomes (EEs) of antigen presenting cells, especially of dendritic cells, less 
in macrophages23. Class II MHC is synthesized and assembled in the endoplasmatic reticulum (ER), 
directed via the invariant chain li either directly to EEs or more commonly to the plasma membrane, 
from where it is internalized again by endocytosis24. Newly synthesized class II MHC-li complexes are 
processed mainly by cathepsin S, before peptide loading (reviewed in25). Of similar importance, class 
II MHC loaded complexes reside primarily in late endosomes (LEs)26. By contrast, mature lysosomes 
Figure 5. Binding to cathepsin S is pH-dependent and differs significantly between Bet v 1 isoforms. (a) 
Binding of Bet v 1a (10 μ M) to immobilized cathepsin S was weak at near neutral pH values (8.5, 7.4 and 
6.7). Only at acidic pH (pH ≤ 5.5) binding affinity increased significantly. (b) By contrast, binding affinity 
of Bet v 1d (10 μ M) to cathepsin S increased continuously with decreasing pH, except for pH 7.4 where 
weakest binding was observed. Results for 2 independent measurements are shown.
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at more acidic pH values contain only little class II MHC and are unlikely to generate any functional 
peptide loaded complex27.
In conclusion, hypoallergenic variants such as Bet v 1d are largely processed within the LE by cathep-
sin S, with a preferential class II MHC loading with Bet v 1d-derived peptides. The resulting high den-
sity of Bet v 1d-mediated synapses of APCs with naïve T-cells induces their polarization to TH1 cells 
with a protective immune response. In contrast, the Bet v 1a-mediated APC—T cell synapses are sparse 
and consequently induce the polarization of T cells into TH2 with an allergic immune response. Large 
amounts of endocytosed Bet v 1a are necessary to maintain the continuous supply of loaded class II 
MHC complexes at low dose, critical for TH2 polarization28. The majority of Bet v 1a protein will be 
completely recycled along the degradation pathway in the LE and the lysosome at acidic conditions 
(pH ≤ 4.5; Fig. 6). Finally, the here provided concept of pH-dependent proteolytic resistance of allergen 
offers new treatment options for allergic patients. The in vitro screening for and identification of orally 
available low molecular weight compounds that expose the cryptic proteolytic recognition sites in aller-
gens have the potential to induce an immune protection, similar like specific immune therapy.
Figure 6. pH-dependent proteolytic resistance of Bet v 1a and 1d selects for the protein degradation 
and antigen presentation pathway, respectively. Bet v 1a mostly escapes the antigen presentation 
pathway, because its cleavage sites are cryptic at pH ≥ 5.5; therefore the majority of Bet v 1a ends up in 
the degradation pathway. By contrast, Bet v 1d is readily processed in the antigen presentation pathway 
with pH ≥ 5.5. Consequently, large amounts of Bet v 1d-derived peptides will be loaded and presented on 
class II MHC, explaining the protective TH1 response. The large amounts of endocytosed Bet v 1a allergen 
together with its low proteolytic processing at pH ≥ 5.5 warrant a continuous supply of Bet v 1a peptides for 
presentation albeit at low concentration, thus explaining its allergic TH2 response. pH values for the early 
endosome (EE, pH 6.8-5.5), the late endosome (LE, pH 5.5-5) and the lysosome (pH 5-4) are approximate 
values as reported in the literature21,36,37.
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Methods
Cloning, expression, and purification of cathepsin S. Human procathepsin S cDNA clone 
BC002642 was obtained from GeneCopoeia (Rockville, US). For subcloning of expression con-
structs Escherichia coli strain XL2 Blue (Stratagene, La Jolla, USA) was used. To obtain glyco-
sylated protein, procathepsin S was expressed in the Leishmania tarentolae system (LEXSY; Jena 
Bioscience, Germany). The encoding DNA was amplified by polymerase chain reaction (Eppendorf 
Mastercycler ep gradient thermal cycler) with human cathepsin S full-length cDNA clone 
BC002642 as template and primers containing an XbaI restriction site and six codons for histidine 
(CCTCTCTAGAGCACCACCATCACCACCACGTGGCACAGTTGCATAAAGATCCTA CCCTG) and 
a NotI restriction site (GAGGGCGGCCGCTCACTAGATTTCTGGGTAAG). The PCR product was 
cloned into the pLEXSY-sat2 vector using the XbaI and NotI restriction sites. Point mutations C25A 
and S21C were introduced with ‘Round-the-horn’ site-directed mutagenesis29. All expression constructs 
contain an N-terminal signal sequence for secretory expression, followed by an N-terminal His6-tag for 
purification, which remains with the propeptide after autoactivation. The identity of expression con-
structs was confirmed by DNA sequencing. Stable transfection of expression constructs into the LEXSY 
P10 host strain was achieved by electroporation, and subsequent selection of positive clones was per-
formed via addition of nourseothricin (Jena Bioscience). Cells were grown at 26 °C in BHI medium 
(Jena Bioscience) supplemented with 5 μ g/ml hemin, 50 units/ml penicillin and 50 μ g/ml streptomycin 
(Carl Roth). Large-scale expression was carried out in 500 ml shaking flasks at 26 °C until OD600≈3 was 
reached. Recombinant procathepsin S was purified from the LEXSY supernatant via Ni–NTA superflow 
resin (Qiagen, Hilden, Germany). Eluates in 400 mM NaCl, 20 mM Tris-HCl pH 8, 300–500 mM imi-
dazole were concentrated using Amicon Ultra centrifugal filter units (3 kDa molecular-weight cutoff, 
Millipore). For long-term storage of procathepsin S the buffer was changed to 20 mM Tris pH 8, 20 mM 
NaCl, 5 mM DTT using NAP-5 desalting columns (GE Healthcare). For autoactivation wild-type proca-
thepsin S was incubated in a buffer composed of 5 mM EDTA 2.5 mM DTT and 100 mM sodium acetate 
pH 4.0 for up to 24 h at 37 °C. To activate the C25A active site dead mutant, the buffer was set to 100 mM 
NaCl, 5 mM EDTA, 10 mM sodium acetate pH 5, and human legumain produced as described in30 was 
added at a ratio of ≈ 1:500, and incubated at 30 °C for at least 2 h. To remove uncleaved procathepsin S 
and the non-covalently bound prodomain, the pH of the buffer was raised to pH 8, and the samples were 
again applied to Ni-NTA columns. The flow through contained mature cathepsin S.
Expression and purification of Bet v 1a and 1d. Recombinant Bet v 1a and Bet v 1d were expressed 
in Escherichia coli strain BL21(DE3) as non-classical inclusion bodies. The expression construct was 
cloned into a modified pET-28b vector, lacking the N-terminal His6-tag. Cells were grown in 600 ml LB 
medium supplemented with 20 μ g/ml kanamycin at 37 °C to an OD600 of 1.0. Expression was induced 
with 1 mM IPTG, and cells were harvested after 4 h. Purification of the non-tagged Bet v 1 was per-
formed with acidic salt precipitation, hydrophobic interaction (phenyl-sepharose) and anion exchange 
(diethylaminoethano–sepharose) chromatography as previously published31. Additionally size exclusion 
chromatography was applied as a final purification step, using a Superdex75 column (GE Healthcare). 
Purified Bet v 1 was stored in 20 mM imidazole, pH 7.4, and 50 mM NaCl at − 80 °C.
Proteolytic processing assay. Bet v 1a and Bet v 1d (c = 0.25 mg/ml) were dialyzed against a buffer 
composed of 100 mM NaCl, 5 mM EDTA, 2 mM DTT and 10 mM sodium acetate pH 5, and spin-filtrated 
before protease digestion. 120 μ l of Bet v 1 were mixed with 25 μ l activated cathepsin S (0.1 mg/ml in 
100 mM NaCl, 5 mM EDTA, 2 mM DTT and 10 mM sodium acetate pH 5), and incubated at 37 °C. This 
corresponds to a ratio of 1:10 protease to substrate. 20 μ l samples were taken after 0, 0.5, 1, 3, 5 and 24 h. 
In a control experiment Bet v 1 supplemented with 25 μ l buffer without addition of cathepsin S was 
incubated for 24 h at 37 °C.
Interaction studies using SAW-technology (Surface Acoustic Waves). The sam® 5BLUE bio-
sensor instrument (nanotemper, Munich, Germany) was used to test the interaction of different Bet v 
1 isoforms with cathepsin S. In trans activated C25A-cathepsin S was coupled to the surface of a sam 
short-chain COOH sensor chip. The protein was incubated in a buffer composed of 20 mM sodium 
acetate pH 5.0, 100 mM NaCl, 1 mM EDTA and 0.5 mM DTT. 240 μ l of a 500 nM cathepsin S solution 
were injected to the chip, which was activated with a 1:1 mixture of 400 mM 1-[3-(dimethylamino)pro-
pyl]-3-ethylcarbodiimide hydrochloride (EDC) and 100 mM N-hydroxysuccinimide (NHS). Sequential 
injection of increasing ligand concentrations (Bet v 1 isoforms) were performed to calculate the affinity 
constant KD. Freshly spin-filtered Bet v 1 samples were applied at concentrations of 5 μ M to 100 μ M in a 
buffer composed of 20 mM imidazole pH 6.7, 50 mM NaCl. For the measurement of heat-destabilized Bet 
v 1a and 1d samples, protein concentrations of 10 to 100 μ M and 2.5 to 40 μ M were used, respectively. 
The coated chip was equilibrated in the same buffer. Between each injection residual ligand was removed 
with regeneration buffer (10 mM citric acid pH 3.0). Experiments were repeated with two individually 
coated chips. SAW phase changes were recorded and used to calculate the affinities based on pseudo-first 
order kinetics (kobs), from which the apparent dissociation constants KD app were determined by linear 
regression. Fitmaster, a customized add-on for Origin (OriginLab, Northampton, MA) was used to fit 
the raw data. Best fitting was obtained when an incomplete regeneration (uncoupled kdiss) was chosen 
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as mathematical model. To test the effect of pH on Bet v 1 binding 10 μ l of each isoform (a and d) were 
dialyzed against five different buffers (20 mM Tris-HCl pH 8.5, 20 mM PBS pH 7.4, 20 mM imidazole pH 
6.7, 20 mM acetic acid pH 5.5, 20 mM acetic acid pH 4.5, all except PBS were supplemented with 50 mM 
NaCl). The chip was equilibrated with the respective buffer prior to injection of Bet v 1.
Induction and control of destabilized Bet v 1. To destabilize the fold, a 100 μ M stock solution 
of Bet v 1 was incubated for 10 min at 60 °C, close to, but lower than the melting point (Tm = 64 °C; 
quantitative precipitation occurred after 15 to 20 min). Potential high molecular weight aggregates were 
removed by spin filtration. The concentration before and after filtration was controlled by measuring 
the absorption at 280 nm wavelength. To test monodispersity of heat-treated Bet v 1, 70 μ L of a 100 μ M 
stock solution were compared with untreated Bet v 1 samples by dynamic light scattering (Fig. S2). Only 
monomeric Bet v 1 was used to study the binding to cathepsin S.
References
1. Bohle, B. The impact of pollen-related food allergens on pollen allergy. Allergy 62, 3–10, doi: 10.1111/j.1398-9995.2006.01258.x 
(2007).
2. Neudecker, P. et al. Mutational epitope analysis of Pru av 1 and Api g 1, the major allergens of cherry (Prunus avium) and celery 
(Apium graveolens): correlating IgE reactivity with three-dimensional structure. The Biochemical journal 376, 97–107, doi: 
10.1042/BJ20031057 (2003).
3. Mari, A., Wallner, M. & Ferreira, F. Fagales pollen sensitization in a birch-free area: a respiratory cohort survey using Fagales 
pollen extracts and birch recombinant allergens (rBet v 1, rBet v 2, rBet v 4). Clinical & Experimental Allergy 33, 1419–1428, 
doi: 10.1046/j.1365-2222.2003.01773.x (2003).
4. Hauser, M. et al. Bet v 1-like pollen allergens of multiple Fagales species can sensitize atopic individuals. Clinical and experimental 
allergy : journal of the British Society for Allergy and Clinical Immunology 41, 1804–1814, doi: 10.1111/j.1365-2222.2011.03866.x 
(2011).
5. Swoboda, I. et al. Isoforms of Bet v 1, the Major Birch Pollen Allergen, Analyzed by Liquid Chromatography, Mass Spectrometry, 
and cDNA Cloning. Journal of Biological Chemistry 270, 2607–2613, doi: 10.1074/jbc.270.6.2607 (1995).
6. Ferreira, F. et al. Dissection of immunoglobulin E and T lymphocyte reactivity of isoforms of the major birch pollen allergen Bet 
v 1: potential use of hypoallergenic isoforms for immunotherapy. The Journal of Experimental Medicine 183, 599–609, doi: 
10.1084/jem.183.2.599 (1996).
7. Wagner, S. et al. Naturally occurring hypoallergenic Bet v 1 isoforms fail to induce IgE responses in individuals with birch pollen 
allergy. The Journal of allergy and clinical immunology 121, 246–252, doi: 10.1016/j.jaci.2007.08.006 (2008).
8. Reuter, A. et al. Novel isoforms of Pru av 1 with diverging immunoglobulin E binding properties identified by a synergistic 
combination of molecular biology and proteomics. Proteomics 5, 282–289, doi: 10.1002/pmic.200400874 (2005).
9. Constant, S., Pfeiffer, C., Woodard, A., Pasqualini, T. & Bottomly, K. Extent of T-Cell Receptor Ligation Can Determine the 
Functional-Differentiation of Naive Cd4(+ ) T-Cells. Journal of Experimental Medicine 182, 1591–1596, doi: 10.1084/
jem.182.5.1591 (1995).
10. Conus, S. & Simon, H. U. Cathepsins and their involvement in immune responses. Swiss medical weekly 140, w13042, doi: 
10.4414/smw.2010.13042 (2010).
11. Hsing, L. C. & Rudensky, A. Y. The lysosomal cysteine proteases in MHC class II antigen presentation. Immunological reviews 
207, 229–241, doi: 10.1111/j.0105-2896.2005.00310.x (2005).
12. Reich, M. et al. Endocytosis targets exogenous material selectively to cathepsin S in live human dendritic cells, while cell-
penetrating peptides mediate nonselective transport to cysteine cathepsins. Journal of leukocyte biology 81, 990–1001, doi: 
10.1189/jlb.1006600 (2007).
13. Jordans, S. et al. Monitoring compartment-specific substrate cleavage by cathepsins B, K, L, and S at physiological pH and redox 
conditions. BMC biochemistry 10, 23, doi: 10.1186/1471-2091-10-23 (2009).
14. Lutzner, N. & Kalbacher, H. Quantifying Cathepsin S Activity in Antigen Presenting Cells Using a Novel Specific Substrate. 
Journal of Biological Chemistry 283, 36185–36194, doi: 10.1074/jbc.M806500200 (2008).
15. Egger, M. et al. Assessing protein immunogenicity with a dendritic cell line-derived endolysosomal degradome. PLoS One 6, 
e17278, doi: 10.1371/journal.pone.0017278 (2011).
16. Magler, I., Nüss, D., Hauser, M., Ferreira, F. & Brandstetter, H. Molecular metamorphosis in polcalcin allergens by EF-hand 
rearrangements and domain swapping. FEBS Journal 277, 2598–2610, doi: 10.1111/j.1742-4658.2010.07671.x (2010).
17. Cooper, D. R. et al. Protein crystallization by surface entropy reduction: optimization of the SER strategy. Acta Crystallogr D 63, 
636–645, doi: 10.1107/S0907444907010931 (2007).
18. Asam, C. et al. Bet v 1—a Trojan horse for small ligands boosting allergic sensitization? Clin Exp Allergy 44, 1083–1093, doi: 
10.1111/cea.12361 (2014).
19. Delamarre, L., Pack, M., Chang, H., Mellman, I. & Trombetta, E. S. Differential lysosomal proteolysis in antigen-presenting cells 
determines antigen fate. Science (New York, N.Y.) 307, 1630–1634, doi: 10.1126/science.1108003 (2005).
20. Savina, A. et al. NOX2 Controls Phagosomal pH to Regulate Antigen Processing during Crosspresentation by Dendritic Cells. 
Cell 126, 205–218, doi: 10.1016/j.cell.2006.05.035 (2006).
21. Compeer, E. B., Flinsenberg, T. W. H., van der Grein, S. G. & Boes, M. Antigen processing and remodeling of the endosomal 
pathway: requirements for antigen cross-presentation. Frontiers in immunology 3, 37, doi: 10.3389/fimmu.2012.00037 (2012).
22. Brömme, D. et al. Functional expression of human cathepsin S in Saccharomyces cerevisiae. Purification and characterization of 
the recombinant enzyme. Journal of Biological Chemistry 268, 4832–4838 (1993).
23. Lennon-Dumenil, A. M. et al. Analysis of Protease Activity in Live Antigen-presenting Cells Shows Regulation of the Phagosomal 
Proteolytic Contents During Dendritic Cell Activation. Journal of Experimental Medicine 196, 529–540, doi: 10.1084/jem.20020327 
(2002).
24. McCormick, P. J., Martina, J. A. & Bonifacino, J. S. Involvement of clathrin and AP-2 in the trafficking of MHC class II molecules 
to antigen-processing compartments. Proceedings of the National Academy of Sciences of the United States of America 102, 
7910–7915, doi: 10.1073/pnas.0502206102 (2005).
25. van Niel, G., Wubbolts, R. & Stoorvogel, W. Endosomal sorting of MHC class II determines antigen presentation by dendritic 
cells. Current opinion in cell biology 20, 437–444, doi: 10.1016/j.ceb.2008.05.011 (2008).
26. Boes, M. et al. T Cells Induce Extended Class II MHC Compartments in Dendritic Cells in a Toll-Like Receptor-Dependent 
Manner. The Journal of Immunology 171, 4081–4088, doi: 10.4049/jimmunol.171.8.4081 (2003).
27. Harding, C. V. & Geuze, H. J. Immunogenic peptides bind to class II MHC molecules in an early lysosomal compartment. The 
Journal of Immunology 151, 3988–3998 (1993).
www.nature.com/scientificreports/
9Scientific RepoRts | 5:12707 | DOi: 10.1038/srep12707
28. Abbas, A. K., Lichtman, A. H. & Pillai, S. Cellular and molecular immunology. 7th edn, (Elsevier/Saunders, 2012).
29. Moore, S., ‘Round-the-horn site-directed mutagenesis, < http://openwetware.org/wiki/%27Round-the-horn_site-directed_
mutagenesis> (2005) Date of access: 24/05/2015.
30. Dall, E. & Brandstetter, H. Activation of legumain involves proteolytic and conformational events, resulting in a context- and 
substrate-dependent activity profile. Acta Crystallographica Section F Structural Biology and Crystallization Communications 68, 
24–31, doi: 10.1107/S1744309111048020 (2012).
31. Hoffmann-Sommergruber, K. et al. High-level expression and purification of the major birch pollen allergen, Bet v 1. Protein 
Expr Purif 9, 33–39, doi: 10.1006/prep.1996.0671 (1997).
32. Marković-Housley, Z. et al. Crystal Structure of a Hypoallergenic Isoform of the Major Birch Pollen Allergen Bet v 1 and its 
Likely Biological Function as a Plant Steroid Carrier. Journal of Molecular Biology 325, 123–133, doi: 10.1016/S0022-
2836(02)01197-X (2003).
33. Weichenberger, C. X., Byzia, P. & Sippl, M. J. Visualization of unfavorable interactions in protein folds. Bioinformatics 24, 
1206–1207, doi: 10.1093/bioinformatics/btn108 (2008).
34. Thompson, J. D., Higgins, D. G. & Gibson, T. J. Clustal-W - Improving the Sensitivity of Progressive Multiple Sequence Alignment 
through Sequence Weighting, Position-Specific Gap Penalties and Weight Matrix Choice. Nucleic acids research 22, 4673–4680, 
doi: 10.1093/nar/22.22.4673 (1994).
35. Bond, C. S. & Schuttelkopf, A. W. ALINE: a WYSIWYG protein-sequence alignment editor for publication-quality alignments. 
Acta Crystallogr D Biol Crystallogr 65, 510–512, doi: 10.1107/S0907444909007835 (2009).
36. Stoorvogel, W., Strous, G. J., Geuze, H. J., Oorschot, V. & Schwartzt, A. L. Late endosomes derive from early endosomes by 
maturation. Cell 65, 417–427, doi: 10.1016/0092-8674(91)90459-C (1991).
37. Muller, S., Dennemarker, J. & Reinheckel, T. Specific functions of lysosomal proteases in endocytic and autophagic pathways. 
Biochimica et biophysica acta 1824, 34–43, doi: 10.1016/j.bbapap.2011.07.003 (2012).
Acknowledgments
We thank Martina Wiesbauer, Arthur Hinterholzer, Esther Schönauer, Line Hyltoft Kristensen and Stefan 
Kofler for technical help. We appreciate the support by the Austrian Science Funds (FWF) for funding 
(project W_01213).
Author Contributions
E.D. produced cystatin C and human legumain, R.F. performed all other experiments, all authors 
analyzed data. R.F. and H.B. prepared the manuscript.
Additional Information
Supplementary information accompanies this paper at http://www.nature.com/srep
Competing financial interests: The authors declare no competing financial interests.
How to cite this article: Freier, R. et al. Protease recognition sites in Bet v 1a are cryptic, explaining its 
slow processing relevant to its allergenicity. Sci. Rep. 5, 12707; doi: 10.1038/srep12707 (2015).
This work is licensed under a Creative Commons Attribution 4.0 International License. The 
images or other third party material in this article are included in the article’s Creative Com-
mons license, unless indicated otherwise in the credit line; if the material is not included under the 
Creative Commons license, users will need to obtain permission from the license holder to reproduce 
the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
